Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Other Non-Current Liabilities (2023 - 2025)

Historic Other Non-Current Liabilities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $1.7 million.

  • Nuvation Bio's Other Non-Current Liabilities rose 9140.97% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 9140.97%. This contributed to the annual value of $2.1 million for FY2024, which is 48158.64% up from last year.
  • According to the latest figures from Q3 2025, Nuvation Bio's Other Non-Current Liabilities is $1.7 million, which was up 9140.97% from $2.4 million recorded in Q2 2025.
  • Nuvation Bio's 5-year Other Non-Current Liabilities high stood at $2.8 million for Q1 2025, and its period low was $353000.0 during Q4 2023.
  • Over the past 3 years, Nuvation Bio's median Other Non-Current Liabilities value was $1.4 million (recorded in 2024), while the average stood at $1.4 million.
  • Over the last 5 years, Nuvation Bio's Other Non-Current Liabilities had its largest YoY gain of 48158.64% in 2024, and its largest YoY loss of 4825.1% in 2024.
  • Over the past 3 years, Nuvation Bio's Other Non-Current Liabilities (Quarter) stood at $353000.0 in 2023, then skyrocketed by 481.59% to $2.1 million in 2024, then decreased by 15.34% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $2.4 million for Q2 2025, and $2.8 million during Q1 2025.